Every year, the Drughunters competition inspires high school students all over Denmark and ignites an interest that can pave the way for the neuroscience talents of tomorrow, such as Charlotte Amalie Børglum Sørensen.
We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.
With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.
When the COVID-19 lockdown announcement came in March 2020, and thousands of colleagues around the globe transitioned to remote work in a matter of days, the pressure was on IT like never before.
Come join us in making a difference to patients worldwide.
Explore the latest financial developments at Lundbeck.
At Lundbeck, we see patients as people and are committed to support the person behind the disease.
The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.
countries where our products are sold
employees supporting our purpose
year Lundbeck was founded